Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processes

Overview of attention for article published in BMC Health Services Research, August 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 58 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 14 publications that cite this research output.

14

The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.

Appraisal of Novel Oncological Therapies by the Scottish Medicines Consortium and the National Institute for Health and Care Excellence: A Comparative Study of Six Years of Data

Article in Cureus (December 2023)

Patient-based evidence: its role in decision making on end-of-life, orphan, and ultra-orphan medicines

Article in International Journal of Technology Assessment in Health Care (April 2023)

Financing and Reimbursement of Approved Advanced Therapies in Several European Countries

Article in Value in Health (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.